Fidelity International’s Axonics, Inc. Common Stock AXNX Stock Holding History

Fidelity International’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,044,722	Closed	-$142M	–	1001
2024 Q3	$142M	Buy	2,044,722 +3,983	+0.2%	+$273K	0.13%	189
2024 Q2	$137M	Buy	2,040,739 +321,239	+19%	+$21.6M	0.14%	178
2024 Q1	$119M	Buy	+1,719,500	New	+$116M	0.12%	198

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Fidelity International's AXNX Position: Q4 2024 in Review

Fidelity International sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 2,044,722 shares — an estimated $142M sold.

Fidelity International first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $142M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Fidelity International reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Fidelity International sold 2,044,722 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $142M.
Fidelity International first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Fidelity International's Axonics, Inc. Common Stock position peaked at $142M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Fidelity International's 13F filing for Q4 2024, filed 13 Feb 2025.